Dowden Nathan J
Entrada Therapeutics, Inc. · President & COO
Dowden Nathan J is listed in filings as President & COO at Entrada Therapeutics, Inc.. This profile follows SEC Form 4 activity through May 4, 2026, including sale activity. Recent filings connect the profile to Entrada Therapeutics, Inc. (TRDA). The current snapshot covers public activity from Aug 20, 2024 to May 4, 2026. Reported amounts are shown as $230.0K to $155.2K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $155k11.9k shares | SellMar 10, 2026 | $13.05 | $6.89 | |
| $41k3.1k shares | SellMar 9, 2026 | $13.02 | $6.89 | |
| $14k847 shares | SellSep 26, 2024 | $16.00 | $6.89 | |
| $29k1.9k shares | SellSep 9, 2024 | $15.07 | $6.89 | |
| $6.1k399 shares | SellSep 6, 2024 | $15.19 | $6.89 | |
| $432k26.6k shares | SellAug 16, 2024 | $16.26 | $6.89 | |
| $8.4k502 shares | SellAug 16, 2024 | $16.70 | $6.89 |